A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

NCT02242396 · clinicaltrials.gov ↗

COMPLETED

Status

5248

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan
DRUG: Telmisartan hydrochlorothiazide

Sponsor

Boehringer Ingelheim